EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Antidiabetic Evaluation of Novel 2,4-Thiazolidinedione Derivatives Targeting Key Carbohydrate-Digesting Enzymes

Mahendra Gowdru Srinivasa, Shreya Kanchan, Darshan S, Karthik G Pujar, Gurubasavaraj V Pujar, Prashant Nayak

Molecules · 2026

DOI: 10.3390/molecules31183160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Mahendra Gowdru Srinivasa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nitte (Deemed to Be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutical Chemistry, Mangalore 575018, India. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Thiazolidinediones, alpha-Amylases, Glycoside Hydrolase Inhibitors. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a long-term metabolic disease associated with elevated glucose levels in blood and still constitutes one of the major public health issues worldwide. Inhibition of carbohydrate-digesting enzymes like α-amylase and α-glucosidase has been found to be effective in controlling postprandial hyperglycemia. The current study focused on designing, synthesis, characterization, and evaluation of novel 2,4-thiazolidinedione derivatives (D1–D5) as potent antidiabetic drugs utilizing combined in silico, in vitro, and in vivo techniques. Results from drug-likeness and ADME analyses indicated that all synthesized derivatives met Lipinski’s rule of five and had desirable pharmacokinetics properties along with reduced toxicity. Molecular docking against maltase-glucoamylase (human; PDB ID: 3TOP) protein showed good binding affinities of both D1 and D5 derivatives (−7.74 and −7.40 kcal/mol respectively) due to stable interactions with catalytic residues of enzymes. Inhibition of enzymes in vitro showed that D1 and D5 had the highest inhibitory activities of all synthesized derivatives, with IC50 of 33.86 ± 2.1 and 37.55 ± 1.7 μM against α-amylase and 29.81 ± 3.2 and 32.43 ± 1.2 μM against α-glucosidase, respectively. Cytocompatibility tests on L6 myoblast cells proved that the lead compounds were well tolerated. In addition, studies in a model of Drosophila melanogaster induced by a high-sugar diet revealed a significant decrease in the level of glucose concentration depending on the dose, especially for D1 and D5, indicating their antihyperglycemic activity in vivo. Thus, these data confirm that D1 and D5 can be regarded as promising lead compounds for the development of new antidiabetics acting via inhibition of carbohydrate-metabolizing enzymes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsThiazolidinedionesalpha-AmylasesGlycoside Hydrolase InhibitorsAnimalsalpha-GlucosidasesMolecular Docking SimulationHumansStructure-Activity Relationship

Stichwörter der Autor:innen

ADME studiesantidiabetic activitymolecular dockingthiazolidinedione derivativesα-glucosidase inhibition

Substanzen

Hypoglycemic AgentsThiazolidinedionesalpha-Glucosidasesalpha-AmylasesGlycoside Hydrolase Inhibitors2,4-thiazolidinedione

Autor:innen und Institutionen

  • Nitte (Deemed to Be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutical Chemistry, Mangalore 575018, India.
  • Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, India.
  • Nitte (Deemed to Be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Mangalore 575018, India.

Zitieren

APA

Srinivasa, M. G., Kanchan, S., S, D., Pujar, K. G., Pujar, G. V., & Nayak, P. (2026). Synthesis and Antidiabetic Evaluation of Novel 2,4-Thiazolidinedione Derivatives Targeting Key Carbohydrate-Digesting Enzymes. Molecules. https://doi.org/10.3390/molecules31183160

Vancouver

Srinivasa MG, Kanchan S, S D, Pujar KG, Pujar GV, Nayak P. Synthesis and Antidiabetic Evaluation of Novel 2,4-Thiazolidinedione Derivatives Targeting Key Carbohydrate-Digesting Enzymes. Molecules. 2026. doi:10.3390/molecules31183160

BibTeX
@article{Srinivasa2026,
  author = {Srinivasa, Mahendra Gowdru and Kanchan, Shreya and S, Darshan and Pujar, Karthik G and Pujar, Gurubasavaraj V and Nayak, Prashant},
  title = {Synthesis and Antidiabetic Evaluation of Novel 2,4-Thiazolidinedione Derivatives Targeting Key Carbohydrate-Digesting Enzymes},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31183160}
}
Kostenlos starten →